Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motor cortex magnetic stimulation as predictor of citalopram response in major depressive disorder
IRCT20100119003106N43Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of citalopram in major depressive disorder (MDD), sponsored by Islamic Azad University. Primary endpoint: Treatment response rate to citalopram. Started Jan 2023; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20100119003106N43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100119003106N43.